PATENT CLAIM ANALYSIS

Application Number: 15977633
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 30):
A conjugate having a formula\n B-L-(D) n  or a pharmaceutically acceptable salt thereof;\n wherein B is a radical of a PSMA binding ligand having the formula \n wherein * is the point of attachment to L;\n L is a 7 atom linker comprising an alkylenecarbonyl optionally substituted with one or more substituents X 1  selected from the group consisting of alkyl, alkoxy, alkoxyalkyl, hydroxy, hydroxyalkyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, halo, haloalkyl, sulfhydrylalkyl, alkylthioalkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, carboxy, carboxyalkyl, and alkyl carboxylate and; \n D comprises a radioactive isotope of a metal coordinated to a chelating group; and \n wherein n is 1.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15959110', '15606913', '14794482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6679883649769511
- 35 USC 102 Novelty (BERT): 0.5442814012488004
- Combined Prediction Score: 0.6556176686041361
- Mean Citation Score: 294.984832
- Max Citation Score: 379.33395
- Similarity Product: 264.12924582906965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test